Task: Answer the multiple choice question.
Question: Which drug exhibits a -1.832% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) Cc1ccc(/C=N/NC(=S)N2CCOCC2)cc1
b) Cc1cc2nc3n(c2cc1C)CC1CC(C(=O)NCC2CC2)N(C)C31
Answer: b. Cc1cc2nc3n(c2cc1C)CC1CC(C(=O)NCC2CC2)N(C)C31
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc2nc3n(c2cc1C)CC1CC(C(=O)NCC2CC2)N(C)C31
Cc1cc2nc3n(c2cc1C)CC1CC(C(=O)NCC2CC2)N(C)C31
N-(cyclopropylmethyl)-4,5,11-trimethyl-1,8,11-triazatetracyclo[7.6.0.02,7.010,14]pentadeca-2(7),3,5,8-tetraene-12-carboxamide